Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Amsterdam  >  Royal DSM    DSM   NL0000009827

ROYAL DSM

(DSM)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

Royal DSM : DSM will further upgrade its Vitamin C facility in Jiangshan, China in summer 2019

share with twitter share with LinkedIn share with facebook
share via e-mail
0
07/17/2019 | 04:50am EDT

This shutdown has started earlier this month, with the latest upgrades to be completed by start Q4 2019.

DSM assures security of supply of Vitamin C to its contracted customers, also during the shutdown.

Fully aligned with its Quality for Life principles, DSM continuously invests in meeting expectations of customers, governments and employees in terms of quality, reliability, traceability and sustainability. Vitamin C from Jiangshan, China, is already the lowest carbon footprint Vitamin C on the market, thanks to this continuous investment program.

Disclaimer

Koninklijke DSM NV published this content on 17 July 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 17 July 2019 08:49:08 UTC

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ROYAL DSM
08/05ROYAL DSM : Ex-dividend day for optional dividend
FA
08/01Evonik confirms 2019 outlook despite 'gloomy' economy, weaker second-quarter
RE
07/25ROYAL DSM : DSM launches I AM Tomorrow Challenge to drive innovation in 3D print..
PU
07/19ROYAL DSM : DSM files for EU authorization of methane-reducing feed additive
PU
07/17ROYAL DSM : DSM will further upgrade its Vitamin C facility in Jiangshan, China ..
PU
07/16ROYAL DSM : DSM introduces new Delvo®Cheese CH-120 culture range for young chedd..
PU
07/16ROYAL DSM : DSM - repurchase of shares (8 – 12 July 2019)
PU
07/10DSM AND EVONIK TAKE NEXT STEP IN SUS : Veramaris facility in Blair (USA) starts ..
PU
07/09ROYAL DSM : DSM - repurchase of shares (1 - 5 July 2019)
PU
07/08ROYAL DSM : DSM and Avril collaborate to bring plant-based protein to food indus..
PU
More news
Financials (EUR)
Sales 2019 9 228 M
EBIT 2019 1 143 M
Net income 2019 819 M
Debt 2019 1 298 M
Yield 2019 2,24%
P/E ratio 2019 22,5x
P/E ratio 2020 19,5x
EV / Sales2019 2,20x
EV / Sales2020 2,08x
Capitalization 19 026 M
Chart ROYAL DSM
Duration : Period :
Royal DSM Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ROYAL DSM
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Average target price 112,75  €
Last Close Price 107,50  €
Spread / Highest target 27,4%
Spread / Average Target 4,88%
Spread / Lowest Target -35,8%
EPS Revisions
Managers
NameTitle
Feike Sijbesma CEO & Chairman-Management Board
Robert John Routs Chairman-Supervisory Board
Géraldine Matchett Chief Financial Officer
Pauline F. M. van der Meer Mohr Member-Supervisory Board
Victoria Franchetti Haynes Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
ROYAL DSM50.48%20 632
BASF SE-5.88%57 122
DUPONT DE NEMOURS INC-37.61%48 583
GROUPE BRUXELLES LAMBERT6.36%13 874
SASOL LIMITED-36.92%11 443
EVONIK INDUSTRIES AG-1.38%10 966